Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

Swiss drugmaker Roche on Wednesday announced a major deal in the weight-loss category, agreeing to pay up to $5.3 billion to ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Telemedicine operator Teladoc Health Inc (NYSE:TDOC) has entered a pharmacy integration agreement with Eli Lilly And Co's ...

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...